Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)
- 26 June 2012
- journal article
- editorial
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 47 (2), 402-405
- https://doi.org/10.1016/j.ejps.2012.06.009
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Twin screw wet granulation: Effects of properties of granulation liquidPowder Technology, 2012
- Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case StudyIndustrial & Engineering Chemistry Research, 2011
- Process analytical technology (PAT) for biopharmaceuticalsBiotechnology Journal, 2011
- Periodic section modeling of convective continuous powder mixing processesAIChE Journal, 2011
- The problems with today's pharmaceutical business—an outsider's viewNature Biotechnology, 2011
- A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working GroupValue in Health, 2010
- Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applicationsBiotechnology & Bioengineering, 2009
- Enabling personalized cancer medicine through analysis of gene-expression patternsNature, 2008
- The genealogy of lean productionJournal of Operations Management, 2006
- Continuous Processing in the Pharmaceutical IndustryChemical Engineering Research and Design, 2005